Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1033 (LINC01033) is a human gene encoding a long intergenic non-coding RNA (lincRNA). LincRNAs are a large and heterogeneous class of transcripts longer than 200 nucleotides, do not overlap protein-coding genes, and typically modulate gene expression through diverse mechanisms, including chromatin remodeling, RNA stabilization, transcriptional regulation, and acting as molecular scaffolds or decoys. For LINC01033 specifically, there are no detailed functional studies, pathway associations, disease links, or established pharmacological relevance. Its sequence and annotation are validated in multiple databases (GeneCards, BioGPS, Ensembl), but there is no current evidence of therapeutic targeting or use as a biomarker[1][3][5]. Be careful not to confuse LINC01033 with LINC01133, another long non-coding RNA that has been more extensively studied and implicated in oncogenesis and cancer pathways[2]. In summary, LINC01033 is a valid lincRNA gene with no established disease, drug, or biomarker relevance as of the search date.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1033 (LINC01033).